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Effects of Aging and Hypertension on Plasma 
Angiotensin II and Platelet Angiotensin II 
Receptor Density 
Joseph Duggan, Stephen Kilfeather, Eoin O'Brien, Kevin O'Malley, and Jurg Nussberger 
Plasma renin activity (PRA) declines with age in 
normal individuals, but the effect of age on plasma 
angiotensin II (ANG II) is less clear. A decline in 
plasma ANG II with age could result in altered 
platelet ANG II receptor density since plasma hor­
mone levels influence their target organ receptors. 
To investigate this possibility, PRA, plasma ANG 
II, and platelet ANG II receptor density were exam­
ined in 17 young, 12 middle-aged, and 14 elderly 
healthy normotensive volunteers. To assess whether 
hypertension altered receptor density, these vari­
ables were also examined in 23 hypertensive patients. 
In normotensives, there was a negative correla­
tion between age and PRA (r = - 0 . 4 3 , Ρ < .05), no 
significant change in basal plasma ANG II with 
age, and a weak positive correlation between age 
and ANG II receptor density (r = 0.34, Ρ < .05). 
Multiple regression analysis revealed that the rela­
tionship between age and ANG II receptor density 
was independent of the associated rise in mean ar­
terial pressure with age (P < .05). Platelet ANG II 
receptor density was not significantly related to 
PRA or plasma ANG II. ANG II receptor affinity 
did not change with age. Neither PRA nor ANG II 
receptor density or affinity differed between hy­
pertensives and normotensives of similar mean age, 
but plasma ANG II was significantly lower in hy­
pertensives compared with normotensives. 
We concluded that aging is associated with a de­
cline in supine PRA. The small decrease in plasma 
ANG II was not significant. Platelet ANG II recep­
tor density increased with age primarily due to a 
small group of elderly subjects with elevated recep­
tor density. There was no change in ANG II recep­
tor density or affinity in hypertensives despite ap­
parently lower plasma ANG II in these patients. 
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P lasma renin activity declines with age in normal individuals.1"3 This is associated with a fall in plasma aldosterone with a g e . 4 - 6 Most investi­gators have found no change in plasma angio-
Received June 25, 1991. Accepted June 30, 1992. 
From the Department of Clinical Pharmacology, Royal College of 
Surgeons in Ireland, St. Stephens Green, Dublin, Ireland (JD, SK, 
EOB, KOM), and Division of Hypertension, Centre Hopitalier Univer-
sitaire Vaudois, Lausanne, Switzerland (JN). 
We wish to acknowledge the support of the Health Research Board 
(Ireland) and the Research Committee of the Royal College of Sur­
geons in Ireland. 
Address correspondence and reprint requests to Joseph Duggan, 
Department of Geriatric Medicine, University Hospital of South Man­
chester, Manchester, M20 8LR, England. 
tensin II (ANG II) with a g e , 7 - 1 1 although there is a single 
report describing lower plasma ANG II levels in older 
normotensive subjects. This result was, however, ob­
tained after stimulation of the renin-angiotensin system 
by standing for 2 h . 1 2 
Reduced plasma ANG II levels, if present in the el­
derly, could lead to a secondary increase in ANG II 
receptor density and responsiveness. Vascular smooth 
muscle is relatively inaccessible for study in humans, 
but platelets appear to provide an accessible model of 
changes in ANG II receptor density occurring in re­
sponse to changes in plasma ANG II. Platelet recep­
tor density increases and decreases in response to so­
dium loading and restriction, which decrease and 
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increase plasma ANG II levels 1 3 , 1 4 in a similar fashion to 
changes in ANG II receptor density in vascular smooth 
muscle . 1 5 , 1 6 
Hypertension is associated with enhanced pressor re-
sponsiveness to ANG I I . 1 7 However, the mechanism 
underlying this effect is not known. It is possible that 
changes in ANG II receptor density or responsiveness 
associated with changes in circulating ANG II could be 
involved. 
The present study was conducted therefore to ascer-
tain the effect of age and hypertension on plasma ANG 
II and platelet ANG II receptor density. 
METHODS 
Patients and Study Design The normotensive group 
comprised 43 volunteers aged 20 to 74 years. All were 
healthy, living in the community, and were not taking 
any medications. Volunteers provided a medical his-
tory, and underwent a physical examination and routine 
hematological and biochemical screening to confirm 
their status as normal volunteers. 
The hypertensive group comprised 23 patients aged 
23 to 71 years recruited from the hypertension clinic of 
Beaumont Hospital, Dublin. They were either newly 
diagnosed or free of antihypertensive medication for at 
least the 4 weeks prior to the study. A diagnosis of hy-
pertension was based on blood pressure levels above 
160/90 mm Hg or a diastolic (phase V) blood pressure 
in excess of 95 mm Hg, using a conventional mercury 
sphygmomanometer with the patient sitting still for 
5 min, on three separate occasions. The mean arterial 
pressure was calculated as diastolic + 0.33 X pulse 
pressure. All volunteers and patients gave informed 
consent and the protocol was approved by the Beau-
mont Hospital Ethical Committee. 
On the morning of the study, volunteers and patients 
attended the department at 09:00 having fasted since 
21:00. Following the insertion of an indwelling cannula 
for venous blood sampling and 60 min supine rest, the 
blood pressure was recorded using a Hawksley random 
zero sphygmomanometer. A blood sample was then 
withdrawn for the measurement of plasma renin activ-
ity (PRA), plasma ANG II, platelet ANG II receptor den-
sity, and affinity and serum electrolytes. Sodium status 
was assessed by 24-h urinary sodium. 
Laboratory Methods Plasma Renin Activity Assay We 
collected 10 mL blood into prechilled tubes containing 
EDTA as anticoagulant. The sample was immediately 
chilled in ice and centrifuged at 4°C. Plasma was placed 
into prechilled cryotubes, frozen in liquid nitrogen and 
stored at — 80 °C until assayed. The PRA radioimmuno-
assay kits were obtained from Sorin Biomedica, Salug-
gia, Italy (Catalog No: SB-REN-1-M). For the assay of 
renin activity, samples were rapidly thawed into en-
zyme inhibitor solution containing 2,3-dimercaptopro-
pranolol and 8-hydroxyquinoline sulphate as enzyme 
inhibitors. Samples were then preincubated for 1.5 h at 
37°C and at pH 5.5 to 6.0 to generate angiotensin I, or at 
0°C to determine blank values. Assay of generated an-
giotensin I by radioimmunoassay was conducted in an 
ice-bath for 24 h. Separation of antibody bound angio-
tensin I from free angiotensin I was conducted using 
dextran-coated charcoal according to the instructions of 
the kit. 
Plasma ANG II Assay We collected 10 mL blood into 
prechilled plastic tubes containing 0.5 mL of inhibitor 
solution (2% ethanol, 25 mmol/L phenanthroline, 125 
mmol/L Na 2-EDTA, 2 g/Lneomycin). Blood was imme-
diately chilled in ice and centrifuged at 4 °C. Plasma was 
frozen in liquid nitrogen and stored for several months 
at — 80° C until assayed. Plasma ANG II was assayed as 
previously described using solid-phase extraction on 
phenylsilylsilica, high performance liquid chromotogra-
phy, and a very sensitive radioimmunoassay. 1 8 The orig-
inal description of the method mentions within- and 
between-assay precisions (coefficient of variation, CV) 
of 6% and 13%, respectively, for plasma containing 5.7 
fmol/mL; in addition, the spiking of low renin plasma 
with ANG II at 2.5 and 5 fmol/mL gave recoveries with 
a CV of 12.5%. In the meantime, procedures have been 
improved and recoveries of 6 fmol/mL are now 89 ± 
9 % (n = 6) and a sample containing 0.68 fmol/mL re-
cently gave a CV of 7.5% when measured five times in 
the same assay. The detection limit is at 0.1 fmol/mL. 
Platelet ANG II Receptor Density and Affinity Mate-
rials 1 2 5 I -ANG II was purchased from New England 
Nuclear (Boston, MA) at a stated specific activity of 
2,200 Ci/mmol. Bovine serum albumin (BSA), bacitra-
cin, EDTA, and Medium 199 were all from Serva (Hei-
delberg, Germany). [Sar^-Leu^-ANG II was from Sigma 
(St. Louis, MO). 
Platelet ANG II receptor density and affinity were 
measured using a modification of the method described 
by Mann and colleagues. 1 9 We collected 30 mL blood 
into plastic tubes anticoagulated with 3 .8% trisodium 
citrate (TSC) (TSC: blood, 1:5 mL). Platelet rich plasma 
(PRP) was prepared by centrifugation at 100 g for 
15 min at 22°C. PRP was removed, diluted 20-fold with 
buffer (Medium 199, 5 mmol/L EDTA 0.2% BSA, 1 
mg/mL bacitracin, pH 7.4 at 22 °C) and centrifuged at 
1000 g for 10 min. Washing and centrifugation were 
repeated once and platelets were resuspended in 0.5 mL 
of this buffer. Platelets were counted manually, using a 
hemocytometer, and the volume adjusted to yield a final 
concentration of 4 X 10 9 cells/mL. We incubated 8 X 
10 7 platelets with 1 2 5I-angiotensin (25 to 400 pmol/L) in 
a final volume of 80 //L for 120 min at 37°C mol/L in a 
shaking water bath. Duplicate samples were assayed for 
each concentration of labelled ANG II. Nonspecific 
binding was assessed by inclusion of [Sar^Leu^-ANG II 
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(10~ 5 mol/L) at each concentration of labelled ANG II in 
every experiment. Nonspecific binding ranged from 3 to 
1 5 % of the total binding at the region of the angiotensin 
II K d, depending upon the level of specific binding (spe­
cific binding site density) for each individual. Incuba­
tions were terminated by dilution with 2 mL ice cold 
buffer followed by centrifugation at 2000 g for 5 min at 
4 ° C. From each tube 1 mL supernatant was removed for 
confirmation of free ANG II concentration. The re­
mainder of the supernatant was discarded and the pellet 
resuspended in 2 mL ice-cold buffer and centrifuged as 
before. The supernatant was discarded and the radioac­
tivity in the pellets was counted using a y-counter at 
77% count efficiency. Saturation binding curves of spe­
cifically bound radioactivity were analyzed by nonlin­
ear regression using the computer program HYPMIC 
(Elsevier Scientific Publishers, B.V., Amsterdam, The 
Netherlands) to determine ANG II receptor density 
(Bmax) a n d affinity (K d). The Hill slope for each saturation 
binding curve approximated to 1 (n = 66 [normotensive 
and hypertensive], median = 1.023, 9 5 % confidence 
interval = 1.021, 1.035). This suggests the presence of 
one ANG II binding site on the platelet, as has been 
previously described by others. 1 9 
Other Biochemical Methods Plasma and urinary electro­
lytes were measured by standard automated methods. 
Statistical Analysis Where indicated the data were 
analyzed untransformed. Where there was evidence 
that a variable might not be normally distributed, re-
analyses were conducted using an appropriate transfor­
mation; the summary statistics presented for such vari­
ables have been detransformed into their original units. 
Linear regression was performed using the computer 
program Microstat (Ecosoft, UK). Multiple regression 
was conducted with ANG II receptor density as the de­
pendent variable and age, weight, blood pressure, PRA, 
plasma ANG II, and urinary sodium and potassium as 
independent variables. Statistical comparisons between 
groups were performed using analysis of variance 
(ANOVA) or Student's t test as appropriate. Results are 
expressed as means with their 9 5 % confidence limits. 
Significance was set at the conventional 5 % level. 
RESULTS 
Normotensives Subjects were arbitrarily divided into 
three age groups for the purpose of comparison; young 
(20 to 32 years), middle-aged (41 to 59) and elderly (60 
to 74). Baseline clinical and biochemical characteristics 
of the three age groups are shown in Table 1. The groups 
did not differ significantly in their mean body weight or 
serum or urinary electrolytes. Systolic, diastolic, and 
mean arterial pressures increased significantly with age. 
Plasma renin activity declined significantly with age 
(Table 1) and there was a negative correlation between 
age and PRA (r = . - 0.43, Ρ < .05, Figure 1A). Plasma 
ANG II was slightly but not significantly lower in el­
derly than young people (Table 1, Figure IB). A single 
plasma ANG II measurement of 12.7 fmol/mL in a 58 
year old subject was most likely due to a handling error 
and was therefore excluded from the analyses (the data 
were analysed with and without this point and the sig­
nificance of the correlation between age and plasma 
ANG II was not altered). There was a positive correla­
tion between PRA and plasma ANG II (r = 0.37, Ρ < 
.01) and a positive correlation between age and ANG II 
receptor density (r = 0.34, Ρ < .05, Figure 1C). Varia­
tion in ANG II receptor density increased with age. The 
positive correlation was primarily due to five patients 
over age 59 years with a substantially increased receptor 
density. Multiple regression revealed that age was signif­
icantly related to ANG II receptor density and when this 
was adjusted for, no other variables were related to 
ANG II receptor density. ANG II receptor affinity did 
not change with age. The analyses involving PRA, 
plasma ANG II, and platelet ANG II receptor density 
were repeated using only data from those subjects for 
whom all three measurements were available. The rela­
tionships remained unaltered, but because overall sam­
ple size was reduced, significance levels were also 
slightly reduced. Only those analyses using all available 
data are reported. 
Hypertensives Hypertensive patients were compared 
with the middle-aged and elderly normotensive sub­
jects who were of similar mean age. Clinical, hormonal, 
and receptor data of both groups are presented in Table 
2. Plasma ANG II was significantly lower in hyperten­
sives than in normotensives, but neither ANG II recep­
tor density nor affinity differed significantly between 
the two groups. There was a positive correlation be­
tween PRA and plasma ANG II (r = 0.62, Ρ < .01) in 
hypertensive patients. There was no significant correla­
tion between age and PRA, age and plasma ANG II, or 
age and ANG II receptor density. 
DISCUSSION 
In this study the effects of age and hypertension on 
PRA, plasma ANG II, and platelet ANG II receptor den­
sity were examined. The results confirm that plasma 
renin activity falls with age. Supine plasma ANG II de­
clined with age, but the relationship was not significant. 
Platelet ANG II receptor density increased with age in­
dependent of the associated rise in blood pressure, but 
this was primarily due to a number of patients over age 
59 who had increased receptor density. Plasma ANG II 
levels were slightly lower in hypertensives than in nor­
motensives, but platelet ANG II receptor density and 
affinity did not differ between groups. 
This is the first investigation of the effect of age on 
basal plasma ANG II in subjects whose sodium status 
has been assessed. Previous investigations did not incor-
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TABLE 1. BASELINE CLINICAL, HORMONAL, AND PLATELET ANG II 
RECEPTOR DATA IN NORMOTENSIVES 
Young Middle-Aged Elderly 
Age, years 26.7 50.9 65.3 
(24.8-28.6) (46.6-55.2) (62.8-67.8) 
Weight, kg 67.9 73.5 71.3 
(61.9-73.9) (64.6-82.4) (63.6-79) 
Blood pressure, mm Hg 
Systolic 112.2 118.7 129.6* 
(107-117) (112-125) (119-140) 
Diastolic 68.2 77.0 78.1* 
(62.8-73.6) (72.3-81.7) (73.1-83.1) 
Mean 82.9 90.9 95.2f 
(78.5-87.3) (86.3-95.5) (89.3-101) 
PRA, ng/mL/h 0.98 [10] 0.64 [10] 0.30* [11] 
(0.60-1.61) (0.41-1.02) (0.14-0.63) 
Plasma ANG II, fmol/mL 3.97 [16] 3.63 [8] 3.68 [10] 
(2.97-5.31) (2.90-4.53) (2.80-4.81) 
ANG II receptor density, fmol/109 cells 1.61 2.43 2.75 
(0.88-2.94) (1.16-5.10) (1.10T6.89) 
Affinity, pmol/L 56.1 66.6 65.7 
(42.4-74.3) (56.1-79.7) (46.4-92.6) 
Serum sodium, mmol/L 140.5 [16] 139.9 140.8 [13] 
(140-141) (139-141) (139-142) 
Serum potassium, mmol/L 4.4 [16] 4.5 4.5 [13] 
(4.2-4.6) (4.4-4.6) (4.3-4.7) 
Urine sodium, mmol/24 h 144.9 [16] 157.6 169.2 
(118-172) S (121-194) (130-209) 
Urine potassium, mmoL/24 h 81.8 87.1 74.8 
(65.2-98.4) (68.4-106) (58.9-90.7) 
Mean (95% confidence limits for mean). 
* Ρ < .01. 
t Ρ < .001, ANOVA. 
η = 17, young; η = 12, middle-aged; η = 14, elderly; unless otherwise indicated in square brackets. 
porate the measurement of 24-h urinary sodium and 
differences in dietary sodium cannot be excluded as a 
reason for their findings of unchanged plasma ANG II 
with age . 7 " 1 1 In the present study 24-h urinary sodium 
did not differ significantly between young and old sub­
jects and therefore could not be responsible for the find­
ing of similar plasma ANG II in these groups. Previous 
investigations did not use high-performance liquid chro­
matography (HPLC) for the specific measurement of 
angiotensin-(l-8)octapeptide. In the present study, 
plasma derived ANG II was purified by HPLC prior to 
radioimmunoassay. 1 8 Thus, the findings could provide 
more accurate information concerning the effect of age 
on plasma ANG II in humans. 
The PRA fell with age, while plasma ANG II fell 
slightly but not significantly. This is in agreement with 
the findings of Skott and associates in their study of 
normal 85 year old people. 1 1 On the basis of lower PRA, 
lower generation of ANG I and therefore ANG II would 
be expected. We cannot exclude a small amount of ANG 
II being generated in vitro after blood sampling, 2 0 since 
no renin inhibitor was added to the sampling cocktail. 2 1 
However, careful and rapid handling on ice and immedi­
ate freezing of plasma would have minimized this arti­
fact. Furthermore, in vitro generation should accentu­
ate, rather than diminish, age-related differences in 
ANG II concentrations, since less ANG II is formed in 
vitro when less PRA and ANG I is present, 2 0 as is the 
case in the plasma of older subjects. Plasma angiotensin 
converting enzyme was not measured in the present 
study, but is reported to be either unchanged 2 2 ' 2 3 or de­
creased 2 4 ' 2 5 in the elderly. Alternatively, the rate of ANG 
II metabolism may decline with age, but this remains to 
be established. Furthermore, it may be necessary to stim­
ulate the renin-angiotensin system, for example by am­
bulation, to accentuate and thereby detect any differ­
ence in plasma ANG II between young and old. 1 2 
The finding of a positive correlation between age and 
platelet ANG II receptor density supports the results of 
the single previous study in this area. 2 6 However in the 
previous investigation neither plasma ANG II nor uri­
nary sodium were measured and the study was not con­
ducted in healthy volunteers. The elderly group in the 
previous study were all hospital inpatients with dis-
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subjects over age sixty, in a small group of these patients 
receptor density was elevated. 
Another aspect of this study concerns the relationship 
between plasma ANG II and platelet ANG II receptor 
density. From studies involving the manipulation of 
plasma ANG II through changes in dietary sodium it 
appears that ANG II receptors, in common with many 
other receptor types and their respective hormones, un­
dergo reciprocal regulation by circulating ANG II. Thus, 
dietary sodium restriction, which increases plasma 
ANG II, decreases vascular smooth muscle receptor 
density in the ra t . 1 5 , 1 6 Human platelet ANG II receptors 
are regulated in a similar fashion, undergoing a reduc­
tion in receptor density (/ /downregulation , ,) in response 
to sodium restriction. A corresponding increase in re­
ceptor density ("upregulation") occurs in response to 
sodium loading which is associated with reduced 
plasma ANG II l eve ls . 1 3 , 1 4 , 2 8 The higher sodium intake in 
the elderly (169 ν 145 mmol) in the present investigation 
could only have contributed minimally to lower PRA 
and increased receptor density. The difference in uri-
TABLE 2. BASELINE CLINICAL, HORMONAL, AND 
PLATELET ANG II RECEPTOR DATA IN 
HYPERTENSIVES 
10 20 30 40 50 60 
Age, years 
70 80 
FIGURE 1. A. Correlation between age and plasma renin activ­
ity (PRA) in normotensive volunteers (n = 31). B. Relationship 
between age and plasma ANG II in normotensive volunteers (n = 
34). C. Relationship between age and platelet ANG II receptor 
density in normotensive volunteers (n = 43). 
eases, including coronary artery disease, hyperthyroid­
ism and hypothyroidism; in addition, five elderly pa­
tients were hypertensive and all older subjects were 
receiving medication. In the present investigation none 
of these potentially confounding variables was present. 
More recently, the same investigators have found the 
increase in ANG II receptor density to be independent of 
the accompanying age-related increase in ANG II up­
take processes in the platelet. 2 7 In the present study, 
there was a correlation between age and platelet ANG II 
receptor density and increased variation with age. Al­
though receptor density did not increase in many of the 
Normotensives Hypertensives 
Age, years 58.7 55.0 
(55.0-62.4) (48.8-61.2) 
Weight, kg 72.3 70.8 
(66.9-77.7) (64.7-76.9) 
Blood pressure, mm Hg 
Systolic 124.5 175.6 * 
(118-131) (167-184) 
Diastolic 77.6 100.7* 
(74.4-80.8) (97.6-104) 
Mean 93.2 125.7* 
(89.5-96.9) (122-130) 
PRA, ng/mL/h 0.43 [21] 0.43 [20] 
(0.28-0.67) (0.24-0.76) 
Plasma ANG II, 3.68 [18] 2.77 * [20] 
fmol/mL (3.11-4.29) (2.19-3.49) 
ANG II receptor den­ 2.60 3.71 
sity, fmol/109 cells (1.48-4.53) (2.22-6.23) 
Affinity, pmol/L 66.1 66.5 
(54.5-79.7) (60.8-72.8) 
Serum sodium, 140.4 [25] 140.9 
mmol/L (140-141) (140-142) 
Serum potassium, 4.5 [25] 4.4 
mmol/L (4.4-4.6) (4.3-4.5) 
Urine sodium, 163.8 144.1 [20] 
mmol/24 h (139-189) (121-168) 
Urine potassium, 80.5 70.5 [20] 
mmol/24 h (68.9-92.1) (57.8-83.2) 
Mean (95% confidence limits for mean). 
* Ρ < .002, hypertensives compared to normotensives. 
η = 26, normotensives; η = 23, hypertensives; unless otherwise indi­
cated in square brackets. 
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nary sodium was not statistically significant and there 
was no correlation between urinary sodium and either 
PRA or ANG II receptor density. Furthermore, extremes 
of sodium restriction (10 mEq/day) and sodium loading 
(200 mEq/day) are required to demonstrate upregula-
tion and downregulation in ANG II receptor density in 
platelets. 1 3 , 1 4 It appears, therefore, that regulation of 
platelet ANG II receptor density during aging is complex 
and that factors in addition to plasma ANG II are in­
volved. The increase in receptor density is unlikely to be 
due simply to an increase in platelet size with age since 
platelet volume remains constant from early adulthood 
to old age. 2 9 
In agreement with others 1 4 our data suggests that 
platelet ANG II receptor density and affinity are similar 
in normotensives and hypertensives. In the present 
study, the hypertensives and normotensives had similar 
PRA, but plasma ANG II was slightly lower in hyper­
tensives. ANG II receptor density was not, however, 
increased in hypertensives. There was no correlation 
between either PRA or plasma ANG II and ANG II 
receptor density in the hypertensive group. It may be 
that plasma ANG II in the hypertensives was not suffi­
ciently low to result in upregulation of platelet ANG II 
receptor density or, as in normotensives, factors in addi­
tion to circulating ANG II may also influence receptor 
density in hypertensives. Some patients with hyperten­
sion demonstrate enhanced pressor responsiveness to 
infused ANG I I , 1 7 ' 3 0 but factors other than increased 
ANG II receptor density could contribute. 
In conclusion, PRA falls with age. Plasma ANG II also 
fell with age, but the decrease was not significant. Plate­
let ANG II receptor density increased with age primarily 
due to a small group of elderly subjects with elevated 
receptor density. Hypertensives with lower plasma 
ANG II exhibit similar platelet ANG II receptor density 
as normotensives. 
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